ASA Physical Status Classification
This 81-year-old patient with hypertension, CKD stage 3a, hypercholesterolemia, and malignant melanoma should be classified as ASA Class III.
Rationale for ASA III Classification
The ASA classification system defines Class III as "a patient with moderate or severe systemic disease, which does limit their activities" 1. This patient meets this threshold based on the following:
Key Disease Considerations
CKD Stage 3a is the determining factor for ASA III classification. According to the ASA classification guidelines, patients with moderate systemic disease that limits activities fall into Class III 1. CKD stage 3a (eGFR 45-59 mL/min/1.73 m²) represents moderate kidney disease with established organ dysfunction 2, 3.
Hypertension alone would typically warrant ASA II if well-controlled without systemic sequelae 1. However, in the context of CKD, hypertension is both a cause and complication of kidney disease, representing more significant systemic involvement 2.
Hypercholesterolemia is a cardiovascular risk factor but does not independently elevate ASA class unless associated with symptomatic cardiovascular disease.
Malignant melanoma status depends on disease activity and treatment. If the melanoma is localized and treated, it may not significantly impact ASA classification. However, if metastatic or requiring active systemic therapy, this would support ASA III or potentially higher classification.
Clinical Context
Why Not ASA II?
ASA II is reserved for "mild systemic disease that does not limit activities (e.g., controlled hypertension or controlled diabetes without systemic sequelae)" 1. CKD stage 3a exceeds this threshold because it represents established organ dysfunction with implications for medication dosing, fluid management, and perioperative risk 2.
Why Not ASA IV?
ASA IV requires "severe systemic disease that is a constant potential threat to life (e.g., severe congestive heart failure, end-stage renal failure)" 1. This patient's CKD stage 3a does not meet this severity threshold—end-stage renal disease (stage 5) or CKD stage 4 with severe complications would be required 2.
Important Caveats
Age alone (81 years) does not determine ASA class—the classification is based on physiologic status and comorbid disease burden, not chronologic age 1.
Inter-rater variability exists with ASA classification. Studies show moderate agreement (κ 0.53-0.61) between assessors, with patients having multiple comorbidities like hypertension, renal insufficiency, and obesity being most likely to have discordant classifications 4, 5. The addition of ASA-approved examples in 2014 improved classification accuracy 6.
If the malignant melanoma is metastatic or causing significant functional impairment, reconsider upgrading to ASA IV, as this would represent severe systemic disease with life-threatening potential 1.
Document the specific rationale for your ASA classification in the anesthetic record, particularly noting the CKD stage and any functional limitations, as this improves consistency and communication of perioperative risk 5.